1. Superior Comfort in a Single Package
    No wires or bulky data-recording devices, thus providing patient with freedom of movement to carry out normal daily activities. Thinnest integrated digital ECG plaster.
  2. Ultra-low Power with Wide Sensory Mesh
    Longer lasting with enhanced signal acquisition. Provides truly wearable and continuous ECG monitoring for up to 7 days.
  3. Full ECH Disclosure
    Entire ECG complex captured! State-of-the-art electronics increases detection accuracy, sensitivity and data depth. Full cardiac data logging on 3-leads or 12-leads.
  4. Water Resistant
    Fully integrated and encapsulated plaster allows patients to shower and enjoy an active lifestyle, providing added convenience and comfort.

Highly sensitive and accurate

Healthcare professionals can now obtain better quality diagnostics based on continued assessments of meaningful and determinant readings. Patients themselves enjoy a higher quality of care, greater mobility and increased comfort.

Reliable Signals

Proprietary ultra-wide sensory mesh means no single point offailure. Addresses key challenges in human-skin interface (sweat, body hair, movement, etc), leading to cleaner ECG signals.

Enhanced Symptom Capture

Event Button allows patient to highlight portion of symptomatic ECG.

Medical Study Enabler

Easy-to-use, continuous, long-life monitoring systems allows further R&D and studies into heart disorders and other ailments due to recording of full QRS.

Other Vital Signs Monitoring

Can be expanded to include other vital signs such as respiratory rate, blood oxygen levels and movement variations for other applications.

Available in 3- and 12- Lead Models

Provides physicians with options on how much patient data/information needs to be captured.

Product Dimensions

Front Profile

CardioLeaf - Front Profile

Width: 4 cm
Height: 0.6 cm

Top View

CardioLeaf - Top View

Width: 9 cm

Side View

CardioLeaf - Side View

Width: 9 cm

News & Updates

13-14 October 2011

Clearbridge VitalSigns exhibits at TechVenture 2011 held in Marina Bay Sands Expo and Convention Center, Singapore

1 August 2011

Clearbridge VitalSigns' incubator, Clearbridge Accelerator receives investment from Silicon Valley “Super-Angel”

30 April 2011

Clearbridge VitalSigns was formally awareded the prestigious SPRING’s Technology Enterprise Commercialisation Scheme Proof of Value (TECS POV) grant. This is in recognition of our development efforts in translating our ultra-low power consumption ECG-on-Chip into commercial product.

21 January 2011

Clearbridge VitalSigns was featured in the article "Light Device is no Light Weight" in The Straits Times' Home section today. 

17 January 2011

Press Release: New NUS spin-off company to develop novel electrocardiogram to target the US$ 8 billion global patient monitoring market.

8-9 January 2011

Clearbridge VitalSigns conducted a soft launch of the CardioLeaf in Asia Pacific Congenital and Structural Heart Intervention Symposium (APCASH), 2011 in Hong Kong.

Contact

20 Ayer Rajah Crescent
#08-03 Technopreneur Centre
Singapore 139964

t +65 68730668
f +65 68730778
e contactus@clearbridgevitalsigns.com